February 05, 2025

FDA Approves Tocilizumab Biosimilar

FDA approves AVTOZMA after phase III trial confirms equivalence in efficacy, safety, and pharmacokinetics for RA and other inflammatory conditions.

Conexiant

January 29, 2025

Urticaria, Fever, Joint Pain: Beyond Standard Treatment

A 58-year-old woman presents with a 2-year history of antihistamine-resistant urticaria, accompanied by intermittent fevers and joint pain. While glucocorticoids provide temporary relief, symptoms return upon discontinuation. What's your diagnosis?

Conexiant

January 27, 2025

First U.S. H5N9 Bird Flu Outbreak

The U.S. reports its first outbreak of H5N9 avian influenza, adding to the global concern of highly pathogenic avian flu and highlighting the need for large-scale culling.

Reuters

January 24, 2025

Sex and Age Influence Long COVID Risk

"These findings highlight the need to identify biological mechanisms contributing to sex specificity to facilitate risk stratification, targeted drug development, and improved management of long COVID," wrote the study's authors.

Conexiant

January 24, 2025

VA Study Maps GLP-1 Effects Across Systems

Large-scale study of 1.9M veterans identifies previously unreported benefits and risks of GLP-1 receptor agonists across 175 health outcomes, including reduced substance use disorders and increased pancreatitis risk.

Conexiant

January 21, 2025

MIS-C Study: Six-Month Outcomes Highlight Recovery

By six months, 99% of MIS-C patients with reduced left ventricular systolic function had normalization, according to researchers.

Conexiant

January 15, 2025

Bertagnolli to Exit NIH Director Role

NIH director, Dr. Monica M. Bertagnolli, is stepping down after launching major initiatives in women's health and long COVID research, indicating optimism for their continuation under new leadership.

Conexiant

January 15, 2025

Lung Cancer's Paradox: Never-Smokers Outlive Smokers?

New research challenges conventional wisdom as never-smokers with NSCLC present with more advanced disease but achieve median survival of 6.6 years versus 3.9 years in smokers, upending traditional prognostic assumptions.

Conexiant

January 15, 2025

PRKG2: Genetic Link Between SSc and LUAD

PRKG2 expression reveals genetic ties between systemic sclerosis and lung adenocarcinoma.

Conexiant